Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$780M |
| 2 |
Uber
UBER
|
+$708M |
| 3 |
Goldman Sachs
GS
|
+$569M |
| 4 |
Microsoft
MSFT
|
+$430M |
| 5 |
Netflix
NFLX
|
+$415M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$973M |
| 2 |
Intuitive Surgical
ISRG
|
+$872M |
| 3 |
Nike
NKE
|
+$844M |
| 4 |
Edwards Lifesciences
EW
|
+$805M |
| 5 |
Corpay
CPAY
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.66% |
| 2 | Consumer Discretionary | 19.04% |
| 3 | Healthcare | 13.04% |
| 4 | Communication Services | 12.22% |
| 5 | Financials | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Public Service Enterprise Group
PEG
$38.2B
| $30M | 0.04% |
667,430
-440,191
| -40% | -$23.8M |
|
202
Integra LifeSciences
IART
$1.39B
| $29.9M | 0.04% |
670,284
-120,394
| -15% | -$6.32M |
|
|
AVLR
203
DELISTED
Avalara, Inc.
AVLR
| $29.7M | 0.04% |
398,303
+170,436
| +75% | +$13.9M |
|
204
Roper Technologies
ROP
$38.8B
| $29.4M | 0.04% |
94,441
-24,019
| -20% | -$8.51M |
|
205
Varonis Systems
VRNS
$4.73B
| $29.2M | 0.04% |
1,373,934
+172,380
| +14% | +$4.52M |
|
206
Capital One
COF
$134B
| $29.2M | 0.04% |
578,254
-381,139
| -40% | -$33.5M |
|
207
Church & Dwight Co
CHD
$23.7B
| $29.1M | 0.04% |
452,758
+198
| +0% | +$14.1K |
|
208
Biogen
BIIB
$29.8B
| $28.9M | 0.04% |
91,368
+89,297
| +4,312% | +$27.1M |
|
209
Q2 Holdings
QTWO
$3.89B
| $28.3M | 0.03% |
479,418
+173,019
| +56% | +$13.4M |
|
210
East-West Bancorp
EWBC
$18.1B
| $28.2M | 0.03% |
1,095,035
-820,724
| -43% | -$34.2M |
|
|
TPTX
211
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $28.1M | 0.03% |
628,748
+83,298
| +15% | +$4.42M |
|
212
Suncor Energy
SU
$77.9B
| $27.7M | 0.03% |
1,750,754
-161,718
| -8% | -$4.24M |
|
213
GFL Environmental
GFL
$15.2B
| $27.5M | 0.03% |
+1,826,529
| New | +$28.7M |
|
214
Cheniere Energy
LNG
$54.1B
| $27.3M | 0.03% |
814,926
-877,055
| -52% | -$45M |
|
|
LVGO
215
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $27.1M | 0.03% |
950,333
+215,621
| +29% | +$5.58M |
|
|
EVBG
216
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $27.1M | 0.03% |
254,488
+3,371
| +1% | +$331K |
|
|
CXP
217
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $26.4M | 0.03% |
2,113,667
+38,612
| +2% | +$724K |
|
|
WPX
218
DELISTED
WPX Energy, Inc.
WPX
| $26.4M | 0.03% |
8,656,051
-768,553
| -8% | -$7.25M |
|
219
Molina Healthcare
MOH
$10.2B
| $26.2M | 0.03% |
+187,642
| New | +$25.1M |
|
220
IDEX
IEX
$17.2B
| $26.2M | 0.03% |
189,692
-14,759
| -7% | -$2.32M |
|
|
PRNB
221
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $25.7M | 0.03% |
433,306
+111,018
| +34% | +$6.47M |
|
222
Trane Technologies
TT
$101B
| $25.7M | 0.03% |
310,635
+24,252
| +8% | +$2.94M |
|
|
RVNC
223
DELISTED
Revance Therapeutics, Inc.
RVNC
| $25.2M | 0.03% |
+1,702,524
| New | +$35.2M |
|
|
NSA
224
DELISTED
National Storage Affiliates Trust
NSA
| $25.1M | 0.03% |
846,750
-92,906
| -10% | -$3.08M |
|
225
Bright Horizons
BFAM
$4.01B
| $25M | 0.03% |
245,552
-16,449
| -6% | -$2.42M |
|
Similar funds
Jennison Associates's Q1 2020 Portfolio in Review
As of Q1 2020, Jennison Associates held 749 positions worth $82.3B, down 17% from $99.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates withdrew a net $4.86B in Q1 2020, closing 131 positions and reducing 247 holdings. Its most notable exit was Parker-Hannifin, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Atlassian worth $350M.
- Jennison Associates's largest Q1 2020 buy was Atlassian: 2,552,272 shares worth $350M.
- Jennison Associates added most to Eli Lilly in Q1 2020, an estimated $780M increase.
- Jennison Associates's biggest Q1 2020 reduction was Walt Disney, cutting an estimated $973M.
- Jennison Associates fully exited Parker-Hannifin in Q1 2020, selling an estimated $116M.
- Jennison Associates's ten largest holdings make up 40% of its $82.3B portfolio in Q1 2020.
- Jennison Associates opened 131 new positions and closed 131 in Q1 2020.
- Jennison Associates's portfolio value fell 17% quarter-over-quarter to $82.3B.
Based on Jennison Associates's 13F filing for Q1 2020, filed 6 May 2020.